The Weston Family Foundation has announced the Rapid Response 2025 Program.
The Rapid Response Program provides seed funding to catalyze novel, high-risk, high-reward translational research that accelerates the development of therapeutics or tools for neurodegenerative diseases of aging (NDAs). The aim of the Weston Family Foundation is to catalyze and scale science-based approaches to significantly improve the health and well-being of Canadians.
Project Criteria
- Be translational research that can accelerate therapeutic or tool development for neurodegenerative diseases of aging, as defined by the Institute.
- Therapeutics should address unmet needs in the prevention, treatment and/or symptomatic management of NDAs.
- Tools should address challenges in translational research to accelerate the development and/or clinical implementation of therapeutics for NDAs (e.g., biomarkers, drug delivery systems). Projects covering only the discovery/identification of a tool are considered out of scope.
- Have preliminary data to support the hypothesis and feasibility of the project.
Funding
- Up to $300,000 over 18-24 months
Key Dates
- Letter of Intent Deadline: 18 March 2025 | 11am
- Award Announcement: November 2025